Use of PRG4 to improve dynamic visual acuity and higher order aberrations
US11666529B2 · kind B2 · utility
0Cited by
33References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2016 |
| Grant date | Jun 6, 2023 |
| Priority date | — |
| Expiry date | Dec 9, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods involving the therapeutic use of human PRG4 (lubricin) protein, to improve vision, to reduce aberrations such as impaired night vision, halos, and glare, to improve the stability of the tear film, and to homogenize the refractive index of the surface of the eye.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.